DOI: 10.1310/hpj4906-549 Ozturk MA, Kardas Z, Kardas F, Gunes T, Kurtoglu S
Water, Herbal Infusion (Indian gooseberry (Emblica officinalis) fruit*, Guduchi (Tinospora cordifolia) stem*, Lodhra (Symplocos racemosa) bark, Manjistha (Rubia cordifolia) stem*), Aloe (Aloe barbadensis) Leaf Juice, Glyceryl Stearate, Meadowfoam (Limnanthes alba) Seed Oil, Lactobacillus Ferment, Niacinamide, Cetearyl Alcohol, Cucumber (Cucumis sativus) Distillate*, Glycerin, Hemp seed (Cannabis sativa) oil*, Cetearyl Olivate, L-Carnitine, Olive (Olea europaea) Oil*, Sodium Hyaluronate, Vitamin E (non-GMO Tocopherols), Diaminopropionoyl Tripeptide-33 (Preventhelia), Acetyl Tetrapeptide-40 (Telangyn), Ceramide NP, Ceramide AP, Ceramide EOP, Phytosphingosine, Cholesterol, Sorbitan Olivate, Sodium Lauroyl Lactylate, Rosemary (Rosmarinus officinalis) Leaf Extract, Hydoxyethylcellulose, Carbomer, Caprylyl Glycol, Raspberry Ketone, Xanthan Gum, Citric Acid, Sodium Phytate, Potassium Sorbate, Sodium Bicarbonate
Toxicol Res Appl
Importantly, in the pancreatic cancer subgroup, a median overall survival (OS) of 10.7 months was observed, exceeding historical benchmarks for gemcitabine-based regimens (8.510.1 months) ( In the randomized phase II trial conducted by Jameson et al